As part of its proposed Physician Fee Schedule revisions for next year, the U.S. Centers for Medicare & Medicaid Services (CMS) plans to implement an expansion of the 2010 Physician Payment Sunshine Act, which was rolled into the Affordable Care Act. Passed last year as part of a sweeping bill addressing the opioid epidemic, the expansion requires drug companies to report payments made to physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives, as well as to doctors. The payment categories that have to be reported also would be expanded to include debt forgiveness, long-term loans of covered devices or medical supplies, and acquisitions of companies in which a covered recipient has an ownership interest. (See BioWorld, Aug. 1, 2013.)